Mohammed Alyahya

Mohammed Alyahya

Auto-generated profile, based on publicly available information

Mohammed Alyahya

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AAAhmed Almotairy
Ahmed Almotairy
Mashan AlmutairiMashan Almutairi
Mashan Almutairi
AAAbdulmajeed Althobaiti
Abdulmajeed Althobaiti
MAMohammed Alyahya
Mohammed Alyahya
SSSandeep Sarabu
Sandeep Sarabu
Michael RepkaMichael Repka
Michael Repka

31 August 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AAAbdulmajeed A. Althobaiti
Abdulmajeed A. Althobaiti
EAEman A. Ashour
Eman A. Ashour
Mashan AlmutairiMashan Almutairi
Mashan Almutairi
AAAhmed Almotairy
Ahmed Almotairy
MYMohammed Al Yahya
Mohammed Al Yahya
MRMichael A. Repka
Michael A. Repka

30 December 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AAAbdulmajeed A. Althobaiti
Abdulmajeed A. Althobaiti
EAEman A. Ashour
Eman A. Ashour
AAAhmed Almotairy
Ahmed Almotairy
Mashan AlmutairiMashan Almutairi
Mashan Almutairi
MAMohammed AlYahya
Mohammed AlYahya
Michael RepkaMichael Repka
Michael Repka

1 June 2024 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
RARiyad Alzhrani
Riyad Alzhrani
MAMohammed Y. Alyahya
Mohammed Y. Alyahya
MAMohammed Algahtani
Mohammed Algahtani
RFRawan A. Fitaihi
Rawan A. Fitaihi
ETEssam Tawfik
Essam Tawfik
The traditional method of producing medicine using the “one-size fits all” model is becoming a major issue for pharmaceutical manufacturers due to its inability to produce customizable medicines for individuals’ needs. Three-dimensional (3D) printing is a new disruptive technology that offers many benefits to the pharmaceutical industry by revolutionizing the way pharmaceuticals are developed and manufactured. 3D printing technology enables the on-demand production of personalized medicine with tailored dosage, shape and release characteristics. Despite the lack of clear regulatory guidance, there is substantial interest in adopting 3D printing technology in the large-scale manufacturing of medicine. This review aims to evaluate the research efforts of 3D printing technology in the Middle East and North Africa (MENA) region, with a particular emphasis on pharmaceutical research and development. Our analysis indicates an upsurge in the overall research activity of 3D printing technology but there is limited progress in pharmaceuticals research and development. While the MENA region still lags, there is evidence of the regional interest in expanding the 3D printing technology applications in different sectors including pharmaceuticals. 3D printing holds great promise for pharmaceutical development within the MENA region and its advancement will require a strong collaboration between academic researchers and industry partners in parallel with drafting detailed guidelines from regulatory authorities.

13 December 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AAAhmed Almotairy
Ahmed Almotairy
Mashan AlmutairiMashan Almutairi
Mashan Almutairi
AAAbdulmajeed Althobaiti
Abdulmajeed Althobaiti
MAMohammed Alyahya
Mohammed Alyahya
SSSandeep Sarabu
Sandeep Sarabu
Michael RepkaMichael Repka
Michael Repka

8 September 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
AAAbdulmajeed A. Althobaiti
Abdulmajeed A. Althobaiti
AYAhmed Adel Ali Youssef
Ahmed Adel Ali Youssef
AAAhmed Almotairy
Ahmed Almotairy
Mashan AlmutairiMashan Almutairi
Mashan Almutairi
MAMohammed Alyahya
Mohammed Alyahya
AAAbeer Abdulghani Alkhodier
Abeer Abdulghani Alkhodier